The service will be available to hospital systems and clinical labs in the state to help increase monkeypox testing efficiency, capacity and turnaround time by using a real-time PCR test, according to a Sept. 6 news release.
Testing will take place at the company’s molecular diagnostics laboratory in Stony Brook, N.Y., which will act as a reference lab to support a high volume of tests from clients in the area.
There are more than 20,000 confirmed cases of monkeypox in the U.S. as of Sept. 6, according to the CDC.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.